Linked Life Data

2274937

Source:http://linkedlifedata.com/resource/pubmed/id/2274937

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
29
pubmed:dateCreated
1991-2-26
pubmed:abstractText
New light has recently been shed on transfusion therapy. Early recurrence of cancer, ill effects on the immune system and increased incidence of postoperative infections have all been suggested as possible complications of overenthusiastic transfusion therapy. The need for perioperative transfusions has been overestimated in the past, since new physiological investigations show that a hemoglobin level of 8 g/100 ml can be tolerated at elective surgery provided that the patient is normovolemic and normothermic. Neither has the danger of virus contamination been entirely eliminated. With this in mind, blood component therapy, giving erythrocytes and plasma components according to documented need, has been started. The article describes our institution's suggested policy for transfusion therapy and volume treatment in elective and trauma surgery.
pubmed:language
nor
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0029-2001
pubmed:author
pubmed:issnType
Print
pubmed:day
30
pubmed:volume
110
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3725-8
pubmed:dateRevised
2008-7-16
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
[Transfusion therapy and volume treatment in elective surgery and traumas].
pubmed:affiliation
Kirurgisk avdeling, Sentralsjukehuset i Rogaland, Stavanger.
pubmed:publicationType
Journal Article, English Abstract, Review